Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells.
Somatostatin (SST), an important neuropeptide of the gastrointestinal tract has been shown to stimulate sodium chloride absorption and inhibit chloride secretion in the intestine. However, the effects of SST on luminal butyrate absorption in the human intestine have not been investigated. Earlier studies from our group and others have shown that monocarboxylate transporter (MCT1) plays an important role in the transport of butyrate in the human intestine. The present studies were undertaken to examine the effects of SST on butyrate uptake utilizing postconfluent human intestinal epithelial Caco2 cells. Apical SST treatment of Caco-2 cells for 30-60 min significantly increased butyrate uptake in a dose-dependent manner with maximal increase at 50 nM ( approximately 60%, P < 0.05). SST receptor 2 agonist, seglitide, mimicked the effects of SST on butyrate uptake. SST-mediated stimulation of butyrate uptake involved the p38 MAP kinase-dependent pathway. Kinetic studies demonstrated that SST increased the maximal velocity (V(max)) of the transporter by approximately twofold without any change in apparent Michaelis-Menten constant (K(m)). The higher butyrate uptake in response to SST was associated with an increase in the apical membrane levels of MCT1 protein parallel to a decrease in the intracellular MCT1 pool. MCT1 has been shown to interact specifically with CD147 glycoprotein/chaperone to facilitate proper expression and function of MCT1 at the cell surface. SST significantly enhanced the membrane levels of CD147 as well as its association with MCT1. This association was completely abolished by the specific p38 MAP kinase inhibitor, SB203580. Our findings demonstrate that increased MCT1 association with CD147 at the apical membrane in response to SST is p38 MAP kinase dependent and underlies the stimulatory effects of SST on butyrate uptake.
Saksena
Seema
S
Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois at Chicago and Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois 60612, USA. saksena@uic.edu
Theegala
Saritha
S
Bansal
Nikhil
N
Gill
Ravinder K
RK
Tyagi
Sangeeta
S
Alrefai
Waddah A
WA
Ramaswamy
Krishnamurthy
K
Dudeja
Pradeep K
PK
D051926:Basigin / Q000378:metabolism; D002087:Butyrates / Q000378:metabolism; D018938:Caco-2 Cells; D002462:Cell Membrane / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000166:cytology*; D007700:Kinetics; D027501:Monocarboxylic Acid Transporters / Q000378:metabolism*; D010456:Peptides, Cyclic / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D017481:Receptors, Somatostatin / Q000819:agonists; D013004:Somatostatin / Q000494:pharmacology*; D027981:Symporters / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D000099233:Monocarboxylate Transport Protein 1
D051926:Basigin; D002087:Butyrates; D007093:Imidazoles; D027501:Monocarboxylic Acid Transporters; D010456:Peptides, Cyclic; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D017481:Receptors, Somatostatin; D013004:Somatostatin; D027981:Symporters; D048051:p38 Mitogen-Activated Protein Kinases; D000099233:Monocarboxylate Transport Protein 1; C497886:BSG protein, human; C101130:somatostatin receptor type 1; C040968:seglitide; C093733:somatostatin receptor 2; C093642:SB 203580